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Abstract 24 
 25 
Objective:  To examine hip contact force (HCF), calculated through multibody modelling, in a large 26 
total hip replacement (THR) cohort stratified by patient characteristics such as BMI, age and 27 
function. 28 
Design: 132 THR patients undertook one motion capture session of gait analysis at a self-selected 29 
walking speed. HCFs were then calculated using the AnyBody Modelling System. Patients were 30 
stratified into three BMI groups, five age groups, and finally three functional groups determined by 31 
their self-selected gait speed. Independent 1-dimensional linear regression analyses were performed 32 
to separately evaluate the influence of age, BMI and functionality on HCF, by means of statistical 33 
parametric mapping (SPM). 34 
Results: The mean predicted HCF were comparable to HCFs measured with an instrumented 35 
prosthesis reported in the literature. The regression analyses revealed a statistically significant 36 
positive relationship between BMI and HCF, indicating that obese patients are more likely to 37 
experience higher HCF during most of the stance phase, while a statistically significant relationship 38 
with age was found only during the late swing-phase. Patients with higher functional ability 39 
exhibited significantly increased peak contact forces, while patients with lower functional ability 40 
displayed a pathological flattening of the typical double hump force profile.  41 
Conclusions: HCFs experienced at the bearing surface are highly dependent on patient 42 
characteristics.  BMI and functional ability were determined to have the biggest influence on contact 43 
force. Current preclinical testing standards do not reflect this.  44 
Keywords: Total hip replacement, Hip contact force, Stratification, Biomechanics, Gait 45 
 46 
 47 
 48 
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Introduction 49 
 50 
Total hip replacement (THR) surgery is commonly regarded as one of the most successful elective 51 
orthopaedic surgeries of the 20th century 1. It alleviates pain in patients suffering from debilitating 52 
hip osteoarthritis and improves function. However there is some lifetime risk of implants requiring 53 
revision, the rates of which are currently 4.4% at 10 years and 15% at 20 years2. Epidemiological 54 
studies have provided evidence to suggest that patient characteristics, such as age, BMI and gender 55 
are important factors in the survivorship of hip implants2, 3. One in three patients undergoing THR at 56 
< 50 years of age are expected to require revision surgery during their lifetime, with risks of one in 57 
five for patients 50 to 59 years, one in ten for patients 60 to 69 years, and one in 20 for patients ≥ 70 58 
years 4.  The revision risk for younger patients is consistently higher than for older patients at all 59 
time-points i.e. 5, 10, 15 and 20 years and gender also seems to affect risk 2. Men aged younger than 60 
70 years old have an increased revision risk compared to female patients, and at the age of 50 years 61 
females have a 15% lower chance of revision compared to their male counterparts. BMI also 62 
contributes to lifetime revision risk, with obese patients having twice the risk of revision at 10 years 63 
compared to healthy weight and overweight patients, and it has been suggested by Culliford et al. 5 64 
that for every unit increase of BMI, there is a 2% increased risk of revision of a THR. 65 
The precise reason for these differences in revision rates between patient sub-groups is not clear, 66 
however the variations in revision rates suggest that the demands placed on the implant likely differ 67 
between patient groups. Due to the relatively small sample sizes typically employed in 68 
biomechanical studies of THR cases, few studies have explored how patient characteristics can 69 
differentially influence function post THR, and ultimately how those characteristics might affect 70 
what demand is placed on the implant. 71 
 72 
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In these few studies age and BMI have been shown to influence function in THR patients. In one 73 
analysis of a larger sample of patients from multiple retrospective studies, Foucher et al.6 found that 74 
older patients had limited hip sagittal ROM and hip power generation compared to younger patients 75 
who recovered better post-operatively. When stratifying gait function by age in a large cohort 76 
(n=134) of THR patients, Bennett et al.7, 8 reported that gait kinematics and kinetics were not 77 
influenced by age, except for a reduced ROM exhibited in an 80 years and over age group, a finding 78 
also consistently observed in healthy control patients of a similar age range9. Foucher et al. 6 10 79 
reported that BMI plays a role in recovery, with higher BMI patients having a reduced hip range of 80 
motion (ROM) and hip abductor moment compared to healthy control participants. Furthermore, 81 
lower BMI was associated with higher postoperative values of sagittal ROM, adduction moments, 82 
and external rotation moments compared to THR patients with a higher BMI. 83 
 84 
As described above, real-world patient function 10 and survivorship of the hip implant 2 is affected by 85 
the characteristics of the patient, although this is not currently reflected in preclinical wear testing 86 
standards such as ISO 14242. Current preclinical testing protocols use a stylised waveform vaguely 87 
representing a ‘standard’ THR patient’s walking cycle to test the wear properties of the implant. A 88 
recent study found that post-operative patient function accounts for 42% to 60% of wear, compared 89 
to surgical factors which account for 10% to 33% of wear 11, emphasising the importance of 90 
understanding how gait varies between different patient groups. No previous studies have tried to 91 
understand how patient characteristics affect the absolute forces at the bearing surface, forces 92 
which arguably will have the most influence on in vivo wear rates.  Instrumented implants have been 93 
used to calculate contact force at the bearing surface 12, 13, however the data available from these 94 
implants is limited to small numbers of patients and extrapolating these data to the wider patient 95 
population is not appropriate. Modern computational models of the musculoskeletal system can be 96 
used to calculate joint contact forces and are becoming increasingly more clinically applicable 14. 97 
These models have the capability to calculate accurate joint contact forces in THR patients 15, and 98 
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can be used to predict and compare contact forces in stratified samples derived from a large patient 99 
cohort 16. The primary aim of this study therefore, was to examine hip contact force (HCF), 100 
calculated through multibody modelling, in a large THR cohort when stratified by patient 101 
characteristics such as BMI, age and function.  102 
Method 103 
 104 
Patients 105 
 106 
132 THR patients were recruited into the study through a clinical database of surgical cases. 107 
Inclusion criteria for the hip replacement group were; between 1-5 years THR post-surgery, older 108 
than 18 years of age, no lower limb joint replaced other than hip joint(s), fully pain free and not 109 
suffering from any other orthopaedic or neurological problem which may compromise gait. Ethical 110 
approval was obtained via the UK national NHS ethics (IRAS) system and all participants provided 111 
informed, written consent. 112 
 113 
Data Capture 114 
 115 
Lower limb kinematics and kinetics were collected using a ten camera Vicon system (Vicon MX, 116 
Oxford Metrics, UK) sampling at 100Hz, integrated with two force plates (AMTI, Watertown, MA, 117 
USA) capturing at 1000Hz in a 10m walkway. The operated limb (or most recently operated limb, in 118 
bilateral cases) was used for analysis. All patients were allowed a familiarisation period prior to 119 
completing 3-5 successful trials of each walking condition. A successful trial was defined as a clean 120 
foot strike within the boundary of the force plate. The CAST marker set was used to track lower limb 121 
segments kinematics in six degrees of freedom, with four non-orthogonal marker clusters positioned 122 
over the lateral thighs, lateral shanks and sacrum as described comprehensively elsewhere 17, 18. Six 123 
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retroreflective markers were positioned on the first, second and fifth metatarsophalangeal joints as 124 
well as the malleoli and calcanei. Participants wore a pair of tight-fitting shorts and a vest onto which 125 
reflective markers were affixed using double-sided tape at bony anatomical landmarks to determine 126 
anatomical joint centres. Before walking trials commenced, a static trial was collected in an 127 
anatomical reference position. 128 
 129 
Data Processing 130 
 131 
All markers were labelled and gap-filled using the spline fill function in Vicon Nexus 2.5 (Vicon MX, 132 
Oxford Metrics, UK), before the labelled marker coordinates and kinetic data were exported to 133 
Visual 3D modelling software (C-Motion, Rockville, USA) for further analysis. Kinematic data were 134 
filtered using a low-pass (6Hz) Butterworth filter. Ground reaction force (GRF) data were filtered 135 
using a low-pass Butterworth filter (25Hz) and heel strike and toe-off were determined using 136 
thresholds (>20N for heel strike and <20N for toe off) from the GRF.  137 
 138 
Musculoskeletal modelling 139 
 140 
Musculoskeletal simulations were performed using commercially available software (AnyBody 141 
Modeling System, Version 7.1, Aalborg, Denmark). A recently validated generic musculoskeletal 142 
model 19 was scaled to match the anthropometrics of each patient. The scaling of the model 143 
segments was based on the marker data collected during a static trial 20. Marker trajectories and GRF 144 
data from each gait trial served as input to an inverse dynamics analysis, based on a 3rd order 145 
polynomial muscle recruitment criterion, to calculate muscle forces and HCFs. A total of 494 gait 146 
trials were processed and analyzed through the toolkit AnyPyTools (https://github.com/AnyBody-147 
Research-Group/AnyPyTools).   148 
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The different components of HCFs, defined in a common femur-based reference frame 12 were 149 
computed for the operated limb over a gait cycle. The data were time-normalized from heel-strike 150 
(0%), through toe-off (60%), to heel strike (100%) and interpolated to 1% steps (101 points). An 151 
average per patient was then calculated based on the 3-5 trials collected.  152 
 153 
Stratification by patient characteristics 154 
 155 
Patients were stratified by into three groups based on their BMI. BMI scores were calculated as 156 
measured weight divided by measured height squared (kg/m2). The three groups were; healthy 157 
weight (BMI ≤25 kg/m2); overweight (BMI >25kg/m2 to ≤ 30 kg/m2) and obese (BMI > 30 kg/m2)21. 158 
Patients were also stratified by age into five groups; 1) age 54 to 64 years, 2) 65 to 69 years, 3) 70 to 159 
74 years, 4) 75 to 79, and 5) 80 years and over. 160 
 161 
Stratification by functional ability 162 
 163 
A widely used alternative measure of overall functional ability is gait speed 22, 23. There is some 164 
negative overall correlation between chronological age and gait speed 24, although age has been 165 
shown to only explain 30% of the variance in gait speed 25, suggesting that gait speed itself might be 166 
a unique differential indicator of function compared to age. Furthermore in a recent study 26 167 
suggested that patients walking at a higher gait speed is representative of the high functioning 168 
patients compared to slower patients who would represent the low functioning patients. Therefore, 169 
in the main analysis, in addition to the stratification by age, patients were also stratified into three 170 
functional strata determined by their self-selected gait speed. To define the functional strata, the 171 
mean and standard deviations (SD) of the gait speeds for the whole cohort were determined. All 172 
patients with a gait speed falling within 1SD of the mean were defined as normally functioning (NF). 173 
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Patients with a gait speed greater than 1SD above the mean were defined as high functioning (HF), 174 
and those with a gait speed more than 1SD below the mean were defined as low functioning (LF).  175 
 176 
Data Analysis 177 
 178 
Comparisons were made initially between the HCFs derived from the AnyBody model and the 179 
measured HCFs from the Bergmann Orthoload literature 12. This was to compare absolute values and 180 
ranges between the two populations and to test the validity of the computational model outputs. 181 
Stratified mean peak values and 95% confidence intervals for the resultant force and the three force 182 
components are also reported. 183 
Statistical Parametric Mapping (SPM) analysis 184 
 185 
The computed HCFs were analysed using Statistical Parametric Mapping 27 (SPM, www.spm1D.org, 186 
v0.4, in the Python programming language, www.python.org). Independent linear regression 187 
analyses were performed to evaluate the influence of function, age, and BMI on the magnitude of 188 
the HCFs, as well as on the individual force components. For each linear regression analysis, the t 189 
statistic was computed at each point in the time series, thereby forming the test statistic continuum 190 
SPM{t}, technical details are provided elsewhere 28-30. Significance level was set at α=0.01, and the 191 
corresponding t* critical threshold was calculated based on the temporal smoothness of the input 192 
data through Random Field Theory. Finally, the probability that similar supra-threshold regions 193 
would have occurred from equally smooth random waveforms was calculated. This analysis is based 194 
on the assumptions of random sampling and homology of data 30, as well as normality in the data 195 
distribution. Adherence to the latter assumption was tested by comparing the above-mentioned 196 
parametric linear regression analyses with their non-parametric counterparts 30. The good 197 
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agreement between the two types of analysis, in terms of number, temporal extent, and size of the 198 
supra-threshold clusters, supports the validity of the assumption of data normality. 199 
The results of the three independent, 1-dimensional linear regression analyses from SPM were 200 
further verified by means of 0-dimensional multiple regression analyses. The additional analyses 201 
were run in SPSS (IBM SPSS Statistics for Windows, Armonk, NY, USA) at specific time points during 202 
the gait cycle, corresponding with the peak loads during stance and the local minimum during mid-203 
stance (15, 32, and 48% of the gait cycle). The force values for the 132 patients at each of these time 204 
points, as well as the investigated predictor variables (BMI, age, and gait speed) were normally 205 
distributed. Variance inflation factor (VIF) and Tolerance statistics revealed no multi-collinearity in 206 
the data, while Durbin-Watson statistics confirmed no autocorrelation between residuals. The 207 
assumptions of homoscedasticity and normal distributions of the residuals were also met. 208 
Results 209 
 210 
Patient Demographics 211 
 212 
132 patients took part in the study and the demographics can be found in Table 1.  213 
- Insert Table 1  here - 214 
Musculoskeletal Model Simulations 215 
 216 
The predicted contact forces showed comparable trends and values with measured hip contact force 217 
data. The mean values were comparable with those in the Orthoload published data and the ranges 218 
were generally wider as might be expected from a larger dataset 12  (Figure1 and Table 2).  219 
 220 
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- Insert Table 2 and Figure 1 here - 221 
 222 
Peak Hip Contact Forces 223 
 224 
Stratified mean peak values for the resultant force and the three force components are reported in 225 
full as supplementary data (Supplementary File Table 1).  226 
Statistical Parametric Mapping 227 
 228 
The results of the comparator multiple linear regression analyses were in agreement with the 229 
outcome of the SPM analysis, confirming a statistically significant positive relationship for both BMI 230 
and gait speed with HCF during both the 1st peak and 2nd peak of the stance phase, and a 231 
statistically significant positive relationship for BMI and a negative one for gait speed during the mid-232 
stance valley. For the SPM analysis, only differences which were statistically significant for more than 233 
2% of the gait cycle are discussed. 234 
 235 
BMI 236 
 237 
There was a statistically significant relationship between BMI and the magnitude of the total HCF 238 
(Figure 2a). Obese patients demonstrated significantly increased HCF throughout the loaded stance 239 
phase (8.8 – 53.8%), mid-swing (74.6 – 79.3%), and terminal swing (88.7 – 100%). All the supra-240 
thresholds clusters exceeded the critical threshold t*=3.676 with associated p-values <0.001, 0.003, 241 
and <0.001 respectively. 242 
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The same trends were observed for the proximo-distal component (Figure 2b), for which the test 243 
statistics similarly exceeded the upper threshold t*=+3.678 at 5.4 – 54.3% (p<0.001), 73.5 – 79.2% 244 
(p=0.001), 88.4 – 100% (p<0.001). 245 
In the anteroposterior direction (Figure 2c), statistically significant negative relationship was found 246 
during loading response to mid-stance (10.6 – 29.9%), terminal stance (45.4 – 55.3%), and from mid-247 
swing phase (72.2 – 100%). The clusters exceeded the threshold t*= -3.667 with p-values <0.001. No 248 
significant difference was observed for the medio-lateral component (Figure 2d). 249 
 250 
Age  251 
 252 
There was a statistically significant negative relationship between age and the magnitude of the total 253 
HCF (Figure 3a), however this was limited to the terminal swing phase (90.7 – 98.7%), with the 254 
cluster exceeding the critical threshold t*=-3.660 with p<0.001. This indicates that younger patients 255 
are more likely to experience higher contact forces during this phase. The same trend was observed 256 
for the proximo-distal component, for which the test statistics similarly exceeded the lower 257 
threshold t*=-3.659 at 90.7 – 98.7% of the gait cycle, with an associated p-value <0.001 (Figure 3b), 258 
and for the medio-lateral component at 91.8 – 97.7% of the gait cycle (t*=-3.633, p=0.002) (Figure 259 
3d). In the anteroposterior direction, no statistically significant relationship was found (Figure 3c).  260 
 261 
Function 262 
 263 
The mean gait speed for the functional ability stratum was 0.82 m.s-1 (SD; ±0.08), 1.10 m.s-1 (±0.09) 264 
and 1.37 m.s-1 (±0.09) for LF, NF and HF, respectively. There was a statistically significant relationship 265 
between functional ability and the magnitude of the total HCF (Figure 4a). Patients with a higher 266 
function demonstrated significantly increased HCF during initial contact to loading response (0 – 16% 267 
gait cycle), terminal stance to initial swing (43.8 – 74.1%), and terminal swing (87.8 – 100%). A 268 
statistically significant negative relationship was instead found during mid-stance (27.9-34.9%). All 269 
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the supra-threshold clusters exceeded the critical threshold t*=±3.668, with the chances of 270 
observing similar clusters in repeated random samplings being p<0.001. 271 
The same trends were observed for the proximo-distal component (the dominant component in 272 
terms of magnitude), with the corresponding supra-threshold (t>t*=±3.666) areas spanning from 0 – 273 
15.3%, 45.1 – 73%, 87.7 – 100%, and 27.4 – 35%, respectively (Figure 4b). In the anteroposterior 274 
direction, statistically significant negative relationship was found during initial contact to loading 275 
response (0.6 – 16.3%) and terminal swing (91.6 – 100%), indicating that higher function 276 
demonstrated a significantly increased posterior force during these phases (Figure 4c), while a 277 
statistically significant positive relationship was found during mid-stance (27.3 – 45.9%). All the 278 
clusters exceeded the critical threshold t*=±3.658 with p-values <0.001. Statistically significant 279 
positive relationships were observed for the medio-lateral component during initial contact to 280 
leading response (0-19.8%), terminal stance to mid-swing (43.8 – 75.4%), and late swing phase (91.6 281 
– 100%) (Figure 4d). 282 
 283 
Discussion 284 
 285 
This is the first study to explore the effect of patient characteristics on joint loading through 286 
multibody modelling in a large cohort. We found that resultant HCF varies between different patient 287 
groups and identified systematic differences between strata for BMI and functional ability.  The BMI 288 
strata displayed statistically significant differences in the resultant force throughout most of stance 289 
phase. Few differences were observed between the age strata, whereas the functional strata, 290 
represented by gait speed, displayed the greatest range of statistically significant differences across 291 
the time series (over approx. 60% of the whole gait cycle). Patients with a high functionality had 292 
increased peak loads during the stance phase of the gait cycle, while low functioning patients 293 
displayed a pathological HCF, with a flattening of the typical double hump (Figure 4a). These trends 294 
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were similar when observing the difference in the proximo-distal component of the HCF, albeit 295 
unsurprisingly considering this is the main contributor to the resultant HCF. Our average peak HCF 296 
(2449N) was of a similar magnitude to the HCFs measured with instrumented implants by Bergmann 297 
et al. 12  (2225.7N) (Table 2). No past research has considered the effect of patient characteristics on 298 
HCF and comparison to previous literature is difficult. However, previous work has found that joint 299 
kinematics and forces acting around the joint are affected by different patient characteristics 6-8 and 300 
altered gait variables can affect the magnitude of joint contact forces 31, and therefore this variability 301 
in HCF would be expected.  302 
 303 
BMI 304 
 305 
We found a systematic trend for HCFs to increase with an increasing BMI, and this was expected due 306 
to the increase in body mass which has been previously reported to increase linearly with joint 307 
contact force 32.  These systematic changes in magnitude are a consistent finding in the literature 308 
comparing obese and healthy weight participants when force data are non-normalised, and the 309 
differences between BMI groups tend to disappear when normalised to  body mass 33, which is 310 
common practice in the biomechanical literature exploring function.  In our study we specifically 311 
chose not to normalise HCF to body weight, as we were interested in the absolute magnitude of the 312 
real world forces to which the bearing surface would be exposed. Analysing non-normalised HCFs 313 
may help to explain observed BMI dependant revision rates 2,  as increased loads in preclinical 314 
hardware simulator testing has been shown to increase wear volume and wear particle size 34.  315 
 316 
Age 317 
 318 
When stratified by age there were very few differences observed in HCF in our patient cohort, with 319 
statistically significant differences only found during the terminal swing phase in the proximo-distal 320 
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and resultant forces (90.7 – 98.7%) and medio-lateral component (91.8 – 97.7%), where the hip is 321 
relatively unloaded. Differences in terminal swing phase may be related to the capacity for 322 
individuals to energetically drive the limb forward. Compared to the functional strata, the temporal 323 
range of significance was much less, indicating that grouping patients by age, as a measure of 324 
function, does not differentiate well between patients.  No other study has considered the effect of 325 
age on HCF measures specifically, however in a gait study using conventional motion capture 326 
analysis, Bennett et al. 7, 8 observed little kinematic or kinetic differences between age groups in THR 327 
patients.  As noted previously, the absolute risk of revision in younger patients, can be up to ten 328 
times higher than in older patients 2 and it is likely  that other factors such as overall activity level in 329 
younger patients being higher or younger patients undertaking more demanding adverse loading 330 
activities may contribute more than age-related variability in loads during normal walking. 331 
 332 
Functional ability 333 
 334 
Our results suggest the functional capability of the patient, identified by biomechanical 335 
characteristics, best identifies differences between patient groups. When stratifying patients by gait 336 
speed, not only were peak forces increased in the HF group, but the waveform in the LF group 337 
displayed pathological patterns with a flattening of the transition phase between the two peaks of 338 
axial forces (Figure 4a). A trend was also observed in joint contact forces derived at different walking 339 
speeds, with the slower walking speeds exhibiting a reduced force during the transition between the 340 
peaks 35. This GRF/HCF waveform has been associated with pathological symptoms in patients with 341 
OA or other neurological pathologies 36, suggesting that amongst our patient cohort, all of whom 342 
during screening had self-reported as well-functioning, were patients who were indeed pathological, 343 
identified by different HCF waveforms. Furthermore, those with higher walking speeds exhibit 344 
increased GRFs and joint moments 37, a trend also observed in our HCFs in the function strata. 345 
Patient characteristics such as age and BMI are often controlled for in preclinical testing, whereas 346 
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the real-world functional capability of THR patient is frequently overlooked. Our results suggest that 347 
the functional capability of patients could be the most influential factor in determining forces at the 348 
bearing surface.  349 
 350 
Limitations 351 
 352 
Previous work has identified that simulating different activities in preclinical testing also leads to 353 
increased wear volume 38. In the current study we only analysed walking and in reality patients 354 
perform a number of other daily tasks which can change the overall loading conditions 39 . Walking is 355 
the most commonly performed daily task 40 however, and it is reasonable to suggest that walking 356 
would have a clinically relevant impact on implant performance post-surgery.  Within the multibody 357 
modelling, a number of simulations were run from scaled generic models, and a certain level of error 358 
associated with soft-tissue artefacts and the lack of subject-specific bone geometry and muscle 359 
physiology information might persist.  These models have been previously validated against in-vivo 360 
data from different subjects however 14, 15, 19  with good agreement.  The overall agreement with the 361 
range of measurements from instrumented patients further supports the validity of the current 362 
models’ predictions.  363 
It could be expected that follow up time could have an effect on patient gait and hip contact force 364 
and short-term follow up has shown as much 31, 41. However, patients were recruited between 1-5 365 
years post operatively in an attempt to avoid abnormalities due to post-surgery recovery and 366 
patients mean follow-up time were similar in all groups (Table 1).  367 
Finally, as this study was exploratory in nature we did not analyse any interactions between the 368 
strata. It would be expected that there could be some interactions, for example, between age and 369 
function 23, which could potentially be more clinically relevant. However the analysis of interactions 370 
is not possible in spm1D and therefore we decided to keep the focus of the paper on the temporal 371 
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analysis in the individual strata, as this is relevant for other applications where full waveform data is 372 
required, such as preclinical testing.  373 
 374 
 375 
In conclusion, we have found that the HCF predicted at the bearing surface is highly dependent on 376 
the characteristics of the patient. Conversely, current preclinical laboratory testing standards reflect 377 
only one loading scenario while our study has shown systematic differences in loading patterns 378 
between patient groups (Figures 2-4).  To our knowledge these differences are also not considered 379 
in any in-silico wear prediction models, although more complex waveforms, compared to ISO, have 380 
resulted in greater predicted differences wear volume42, 43. By extension, if future modelling included 381 
patient variability, our data suggest that it is possible that differences in wear rates would also be 382 
predicted. We have to accept that failure of an implant is multi factorial and patient factors and 383 
surgical factors need to be taken into consideration. However if pre-clinical testing were robust 384 
enough to check how implants would perform in different types of patients then patient-dependant 385 
failures could potentially be better predicted. Importantly, patient variability is not considered at all 386 
in current preclinical hardware simulator testing, which determines whether a device new to market 387 
is fit for purpose. It was beyond the realm of this work to test this experimentally in full, but if the 388 
loading profiles generated in this study were used in preclinical hardware tests, it would be expected 389 
that the variability between patient groups found in this study would also be seen in experimental 390 
wear testing 44.  There is certainly a movement towards using different/updated testing procedures 391 
with a number of authors suggesting wear testing under more adverse loads is warranted 44.  392 
Improved preclinical testing, both in silico and in vitro, using more patient stratified waveforms 393 
would highlight where and in whom failures are more likely to occur, allowing for better implant 394 
design and more informed decision making at the time of THR planning for surgeons. Future work 395 
should focus on using patient specific waveforms for in vitro testing to check whether the 396 
differences observed in this study influence experimental wear rates.  397 
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 555 
Figure Legends 556 
 557 
Figure 1. Predicted HCF across the patients’ cohort compared to the measured HCF from the 558 
Orthoload dataset (https://orthoload.com/test-loads/standardized-loads-acting-at-hip-implants/) 12. 559 
Resultant force (blue) and single components – proximo-distal (red), antero-posterior (orange), 560 
medio-lateral (green) – are reported as mean across the cohort (solid line) and overall range of 561 
variation (shaded area) and compared to the corresponding mean and range of variations from the 562 
Orthoload measurements (in grey). Peak values reported in Table 2 are indicated in each plot. 563 
 564 
Figure 2. Predicted hip contact forces across patients reported as a) resultant magnitude, and 565 
individual components: b) proximo-distal, c) antero-posterior, and d) medio-lateral component. The 566 
patients were stratified in Healthy Weight (blue), Overweight (purple) and Obese (red) according to 567 
24 
 
their BMI score.  The upper panels report the averages for each patient strata (solid line) and their 568 
relative 95% confidence intervals. Additionally, the loading profile from the ISO14242-1 testing 569 
standard (dashed grey line) is compared to the proximo-distal forces for each group. The 570 
corresponding lower panels report the results of the SPM linear regression analysis. The significance 571 
α-level was set to 0.01 for each analysis and the corresponding threshold t* are reported (horizontal 572 
dashed lines). Whenever the test statistics continuum SPM{t} exceeds the threshold, significance is 573 
reached and the p-values associated with the supra-threshold clusters (shaded grey areas) are 574 
reported. 575 
 576 
Figure 3. Predicted hip contact forces across patients reported as a) resultant magnitude, and 577 
individual components: b) proximo-distal, c) antero-posterior, and d) medio-lateral component. The 578 
patients were stratified according to their age in five groups: 54:64 (orange), 65:69 (red), 70:74 579 
(grey), 75:79 (blue)  and ≥80  (green).  The upper panels report the averages for each patient strata 580 
(solid line) and their relative 95% confidence intervals. Additionally, the loading profile from the 581 
ISO14242-1 testing standard (dashed grey line) is compared to the proximo-distal forces for each 582 
group. The corresponding lower panels report the results of the SPM linear regression analysis. The 583 
significance α-level was set to 0.01 for each analysis and the corresponding threshold t* are 584 
reported (horizontal dashed lines). Whenever the test statistics continuum SPM{t} exceeds the 585 
threshold, significance is reached and the p-values associated with the supra-threshold clusters 586 
(shaded grey areas) are reported. 587 
 588 
Figure 4. Predicted hip contact forces across patients reported as a) resultant magnitude, and 589 
individual components: b) proximo-distal, c) antero-posterior, and d) medio-lateral component. The 590 
patients were stratified in Low Functioning (purple), Normal Functioning (blue) and High Functioning 591 
(green) according to their self-selected gait speed.  The upper panels report the averages for each 592 
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patient strata (solid line) and their relative 95% confidence intervals. Additionally, the loading profile 593 
from the ISO14242-1 testing standard (dashed grey line) is compared to the proximo-distal forces for 594 
each group. The corresponding lower panels report the results of the SPM linear regression analysis. 595 
The significance α-level was set to 0.01 for each analysis and the corresponding threshold t* are 596 
reported (horizontal dashed lines). Whenever the test statistics continuum SPM{t} exceeds the 597 
threshold, significance is reached and the p-values associated with the supra-threshold clusters 598 
(shaded grey areas) are reported. 599 
  600 
26 
 
Table 1. Patient demographics for each classification strata. Values are reported as mean (SD) unless 601 
otherwise stated. 602 
 603 
  Number of 
patients 
Female:Male Age (Years) BMI (kg/m2) Post-surgery 
(Years) 
All  132 66:66 71.6 (7.6) 28.2(3.8) 2.8 (1.4) 
BMI Healthy Weight 29 18:11 70.1(8.2) 23.4(1.2) 2.6(1.2) 
Overweight 67 31:36 73.2(7.2) 27.6(1.3) 2.8(1.4) 
Obese 36 17:20 69.7(7.0) 33.2(2.2) 3.0(1.6) 
Age 54-64 22 11:11 60.4 (2.9) 28.5(5.3) 2.9(1.5) 
65-69 37 17:20 67.0(1.4) 28.9(3.4) 2.8(1.6) 
70-74 23 14:9 72.3(1.0) 27.8(4.2) 2.1(1.1) 
75-79 28 14:14 77.4(1.2) 28.2(3.0) 2.7(1.3) 
>=80 22 10:12 82.4(3.0) 27.1(2.7) 3.0(1.5) 
Function HF 18 7:11 69.3(6.1) 27.1(2.8) 3.6(1.4) 
NF 97 48:49 71.3(7.7) 28.2(3.8) 2.7(1.4) 
LF 17 11:6 75.8(6.3) 29.3(4.4) 2.7(1.2) 
 604 
 605 
 606 
 607 
 608 
 609 
 610 
 611 
27 
 
Table 2. A comparison of measured peak contact forces 12 and the calculated  peak contact forces  form our study. Values are reported as mean and ranges 
(min-max).    The reported values are highlighted in the corresponding graphs in Figure 1. 
 
Dataset Peak resultant force 
1st peak (R1) (min-
max range) 
Peak resultant 
force 2nd peak (R2) 
(min-max range) 
Peak 
Proximal/Distal 
force 1st peak 
(PD1) (min-max 
range) 
Peak 
Proximal/Distal 
force 2nd peak 
(PD2) (min-max 
range) 
Peak posterior 
force(P1) (min-
max range) 
Peak Anterior 
forces (A1) 
(min-max range) 
Peak 
Medial/Lateral 
force 1st peak 
(ML1) (min-max 
range) 
Peak 
Medial/Lateral 
force 2nd peak 
(ML2) (min-max 
range) 
LLJ dataset 2449.1 
(1310.9 , 3913.5) 
2279.0  
(1093.8 , 3920.5) 
2254.3  
(1179.8 , 3694.4) 
2197.3 
(1030.8 , 3849.1) 
-466.1  
(-838.0 , -232.9) 
-60.5  
(-365.3 , 297.2) 
826.0 
(459.4 , 1353.5) 
599.0 
(273.2 , 1063.3) 
Orthoload 2225.7  
(1793.4 , 3147.0) 
2149.9 
 (1721.2 , 2546.8) 
2085.8  
(1670.1 , 3006.5) 
2073.6  
(1643.8 , 2475.2) 
-405.7 
( -650.4 , -111.4)  
23.5 
(-193.0 , 211.7) 
641.3 
(366.7 , 819.5) 
600.0 
(341.1 , 807.2) 
 
 
